Search Results - "Lněnička, Jaroslav"

Respiratory insufficiency, chronic hypercapnia and domiciliary non-invasive ventilation from the point of view of a pneumologist by Lněnička, Jaroslav

“…Domiciliary non-invasive ventilation has been an established method of treating chronic hypercapnic respiratory insufficiency for decades. Its effectiveness is…”
Get more information

Effect of pirfenidone on lung function decline and survival: 5-yr experience from a real-life IPF cohort from the Czech EMPIRE registry by Zurkova, Monika, Kriegova, Eva, Kolek, Vitezslav, Lostakova, Vladimira, Sterclova, Martina, Bartos, Vladimir, Doubkova, Martina, Binkova, Ilona, Svoboda, Michal, Strenkova, Jana, Janotova, Marketa, Plackova, Martina, Lacina, Ladislav, Rihak, Vladimir, Petrik, Frantisek, Lisa, Pavlina, Bittenglova, Radka, Tyl, Richard, Ondrejka, Gustav, Suldova, Hana, Lnenicka, Jaroslav, Psikalova, Jana, Snizek, Tomas, Homolka, Jiri, Kralova, Renata, Kervitzer, Jan, Vasakova, Martina

“…Pirfenidone, an antifibrotic drug, slows-down the disease progression in idiopathic pulmonary fibrosis (IPF) over 12 months, however limited data on the…”
Get full text

EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis by Doubková, Martina, Švancara, Jan, Svoboda, Michal, Šterclová, Martina, Bartoš, Vladimír, Plačková, Martina, Lacina, Ladislav, Žurková, Monika, Binková, Ilona, Bittenglová, Radka, Lošťáková, Vladimíra, Merta, Zdeněk, Šišková, Lenka, Tyl, Richard, Lisá, Pavlína, Šuldová, Hana, Petřík, František, Pšikalová, Jana, Řihák, Vladimír, Snížek, Tomáš, Reiterer, Pavel, Homolka, Jiří, Musilová, Pavlína, Lněnička, Jaroslav, Palúch, Peter, Hrdina, Roman, Králová, Renata, Hortvíková, Hana, Strenková, Jana, Vašáková, Martina

“…Prognostic factors of idiopathic pulmonary fibrosis (IPF) currently recognized include changes in vital capacity and radiologic findings. However, most of the…”
Get more information

The effect of nintedanib on lung functions and survival in idiopathic pulmonary fibrosis: real-life analysis of the Czech EMPIRE registry by Štefániková, Marianna, Doubková, Martina, Ovesná, Petra, Šterclová, Martina, Lacina, Ladislav, Žurková, Monika, Plačková, Martina, Bartoš, Vladimír, Janíčková, Ivana, Bittenglová, Radka, Anton, Jan, Sýkorová, Ľubica, Lošťáková, Vladimíra, Musilová, Pavlína, Šuldová, Hana, Mokošová, Radka, Didyk, Jurij, Šišáková, Lenka, Lisá, Pavlína, Lněnička, Jaroslav, Dařičková, Hana, Doležel, Daniel, Pšikalová, Jana, Tyl, Richard, Králová, Renata, Vašáková, Martina Koziar

“…The antifibrotic drug nintedanib is used for the treatment of idiopathic pulmonary fibrosis (IPF). We analysed the effect of nintedanib on antifibrotic…”
Get full text

The European MultiPartner IPF registry (EMPIRE): validating long-term prognostic factors in idiopathic pulmonary fibrosis by Tran, Tanja, Šterclová, Martina, Mogulkoc, Nesrin, Lewandowska, Katarzyna, Müller, Veronika, Hájková, Marta, Kramer, Mordechai R, Jovanović, Dragana, Tekavec-Trkanjec, Jasna, Studnicka, Michael, Stoeva, Natalia, Hejduk, Karel, Dušek, Ladislav, Suissa, Samy, Vašáková, Martina

“…Several registries of idiopathic pulmonary fibrosis (IPF) have been established to better understand its natural history, though their size and duration of…”
Get full text